Janssen Pharmaceuticals Inc.

Dec 10, 2017

Medivir Announces Janssen Decision to Terminate its Simeprevir License Effective June 2018

Oct 30, 2017

FDA Approves New 10 mg Dosing for XARELTO® (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)

Sep 26, 2017

Janssen Announces HealtheVoices(TM) Impact Fund Recipients